期刊文献+

1,25-二羟维生素D3通过调节NF-κB和TGF-β1/Smad通路减轻小鼠非酒精型脂肪性肝炎和肝纤维化 被引量:9

Effect of dihydroxyvitamin D3 in regulating NF-κB and TGF-β1/Smad pathway in mice of non-alcoholic steatohepatitis and liver fibrosis
下载PDF
导出
摘要 目的:观察脂肪性肝炎肝纤维化小鼠肝组织NF-κB和TGF-β1/Smad通路的变化以及1,25-二羟维生素D3对其干预作用。方法:将32只C57BL/6J小鼠随机分为空白对照组、蛋氨酸胆碱缺乏(MCD)组、VitD3处理组和hemin处理组。通过饲喂蛋氨酸-胆碱缺乏的食物8周诱导脂肪性肝炎和肝纤维化。用ELISA法检测TGF-β1的变化,用real-time PCR和Western blot方法检测NF-κB和Smad通路中关键分子表达的变化。结果:1,25-二羟维生素D3和hemin的处理减轻了肝脏的损伤,并且抑制了炎症和纤维化相关基因IKK-β、NF-κB、TGF-β1和Smad3的表达,上调了纤维化抑制基因Smad7的表达。结论:NF-κB和TGF-β1/Smad通路参与了非酒精型脂肪性肝炎和肝纤维化的发展,1,25-二羟维生素D3能够通过调节NF-κB和TGF-β1/Smad信号通路减轻肝损伤。 Objective:To investigate the effect of dihydroxyvitamin D3 in regulating NF-κB and TGF-β1/Smad pathway in mice of non-alcoholic steatohepatitis and liver fibrosis.Methods:Thirty-two C57BL/6Jmice fed with methionine-choline deficient(MCD)diet for 8weeks were randomly divided into4groups:normal control group,MCD group,VitD3 group and hemin group.TGF-β1were detected by ELISA and the key molecules expressed in NF-κB and TGF-β1/Smad pathway were measured by realtime PCR and Western blot.Results:Administration of dihydroxyvitamin D3 and hemin can significantly ameliorate mice liver injury by inhibiting the expression of IKK-β,NF-κB,TGF-β1and Smad3 and up-regulating the expression of Smad7.Conclusion:NF-κB and TGF-β1/Smad pathway plays an important role in non-alcoholic steatohepatitis and liver fibrosis and dihydroxyvitamin D3 could attenuate the liver injury by regulating NF-κB and TGF-β1/Smad pathway.
出处 《西北国防医学杂志》 CAS 2016年第8期497-500,共4页 Medical Journal of National Defending Forces in Northwest China
关键词 脂肪性肝炎 肝纤维化 1 25-二羟维生素D3 NF-ΚB TGF-Β1 steatohepatitis liver fibrosis dihydroxyvitamin D3 NF-κB TGF-β1
  • 相关文献

参考文献12

  • 1Day CP,James OF.Hepatic steatosis: innocent bystander or guilty party?. Hepatology . 1998
  • 2Yasuhiro Takano,Hiroaki Mitsuhashi,Koichi Ueno.??1α,25-Dihydroxyvitamin D 3 inhibits neutrophil recruitment in hamster model of acute lung injury(J)Steroids . 2011 (12)
  • 3Anna Grochot-Przeczek,Jozef Dulak,Alicja Jozkowicz.Haem oxygenase-I: non-canonical roles in physiology and pathology. Clinical Science . 2012
  • 4David García-Galiano,Miguel A. Sánchez-Garrido,Isabel Espejo,José Luis Montero,Guadalupe Costán,Trinidad Marchal,Antonio Membrives,José M. Gallardo-Valverde,Juan R. Mu?oz-Casta?eda,Eugenio Arévalo,Manuel Mata,Jordi Muntané.??IL-6 and IGF-1 are Independent Prognostic Factors of Liver Steatosis and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients(J)Obesity Surgery . 2007 (4)
  • 5Metin Basaranoglu,Gokcen Basaranoglu,Tevfik Sabuncu,Hakan Sentürk.Fructose as a key player in the development of fatty liver disease[J].World Journal of Gastroenterology,2013,19(8):1166-1172. 被引量:15
  • 6Metin Basaranoglu,Gkcen Basaranoglu,Hakan Sentürk.From fatty liver to fibrosis:A tale of “second hit”[J].World Journal of Gastroenterology,2013,19(8):1158-1165. 被引量:28
  • 7Michal Cohen-Naftaly,Scott L. Friedman.Current status of novel antifibrotic therapies in patients with chronic liver disease. Therapeutic Advances in Gastroenterology . 2011
  • 8Yoshida Katsunori,Matsuzaki Koichi.Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries. Frontiers in physiology . 2012
  • 9Seki Ekihiro,De Minicis Samuele,Osterreicher Christoph H,Kluwe Johannes,Osawa Yosuke,Brenner David A,Schwabe Robert F.TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nature Medicine . 2007
  • 10FRIEDMAN SL.Liver fibrosis in 2012:Convergent pathways that cause hepatic fibrosis in NASH. Nat Rev Gastroenterol Hepatol . 2013

二级参考文献113

  • 1Deng, Xin,Liang, Jian,Lin, Zhi-Xiu,Wu, Fa-Sheng,Zhang, Ya-Ping,Zhang, Zhi-Wei.Natural taurine promotes apoptosis of human hepatic stellate cells in proteomics analysis[J].World Journal of Gastroenterology,2010,16(15):1916-1923. 被引量:13
  • 2Ruhl CE,Everhart JE.Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology . 2003
  • 3Mozaffarian D,Katan MB,Ascherio A,Stampfer MJ,Willett WC.Trans Fatty Acids and Cardiovascular Disease. New England Journal of Homeopathy . 2006
  • 4Charles S Lieber,Maria A Leo,Ki M Mak,Youqing Xu,Qi Cao,Chaoling Ren,Anatoly Ponomarenko,Leonore M DeCarli.Model of nonalcoholic steatohepatitis. American Journal of Clinic Nutrition . 2004
  • 5Tahan V,Canbakan B,Balci H,Dane F,Akin H,Can G,Ha-temi I,Olgac V,Sonsuz A,Ozbay G,Yurdakul I,Senturk H.Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepato Gastroenterology . 2008
  • 6F Boess,M Kamber,S Romer,R Gasser,D Muller,S Albertini,L Suter.Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicological Sciences . 2003
  • 7Caldwell SH,Chang CY,Nakamoto RK,Krugner-Higby L.Mitochondria in nonalcoholic fatty liver disease. Clinics in Liver Disease . 2004
  • 8Bradbury MW,Berk PD.Lipid metabolism in hepatic steatosis. Clin LiverDis . 2004
  • 9Wang DG,Fan JB,Siao CJ,Berno A,Young P,Sapolsky R,GhandourG,Perkins N,Winchester E,Spencer J,Kruglyak L,Stein L,Hsie L,Topaloglou T,Hubbell E,Robinson E,Mittmann M,Morris MS,Shen N,Kilburn D,Rioux J,Nusbaum C,Rozen S,Hudson TJ,Lipshutz R,Chee M,Lander ES.Large-scaleidentification,mapping,and genotyping of single nucleotidepolymorphism in the human genome. Science . 1998
  • 10Neuschwander-Tetri BA.Hepatic lipotoxicity and the pathogenesiso f nonalcoholic steatohepatitis:the central role of nontriglyceridef atty acid metabolites. Hepatology . 2010

共引文献40

同被引文献77

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部